Stock Market News
Latest financial news · Updated Jul 14, 2026
Up 600% in 2026, Is Sandisk Stock Still a Buy?
The panel consensus is bearish on Sandisk (SNDK) due to data integrity issues, cyclical nature of memory business, and potential …
The Stock Market Could Drop: 2 Urgent Warnings From Former Fed Chair Jerome Powell Explain Why.
The panel agrees that the Strait of Hormuz conflict is the critical binary event, with a potential energy-driven inflation spike …
President Donald Trump's 7-Word Take on Interest Rates Is Due for a Reality Check
The panel agrees that the Iran war's oil disruption has driven up inflation, challenging the Fed's rate target and increasing …
Broadcom Stock Analysis: My Final Verdict
The panel consensus is bearish on Broadcom (AVGO) due to high customer concentration, cyclical demand, integration risks, and a strained …
3 Genius Stocks I'm Buying Instead of the SpaceX IPO
The panel is divided on the investment merit of a hypothetical SpaceX IPO, with concerns raised about execution risks, regulatory …
Make platforms that promote violent content pay towards riot costs, Streeting says
The panel consensus is that UK's push to make social media platforms pay for riot-related costs introduces significant regulatory risks …
Why London BTC is building a Nevada gold portfolio - ICYMI
London BTC's pivot into Nevada gold exploration is risky and may not provide the intended hedge against Bitcoin volatility. While …
Is Abbott (ABT) the Best Longevity Stock to Buy Now?
The panel consensus is bearish, with key concerns being reimbursement uncertainties, competition from Dexcom and Medtronic, and the need for …
Pfizer (PFE): The Best Longevity Stock to Buy Now
The panelists generally agreed that Pfizer's recent updates offer near-term catalysts and pipeline optionality, but they also highlighted significant risks …
Ultra-rich Americans are moving cash out of the market and hoarding historic levels. Here’s where they’re putting it
The panel discusses the 20% cash allocation among ultra-wealthy individuals, with mixed views on whether it signals risk-off sentiment or …
London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’
The panel is divided on Poolbeg Pharma's POLB 001 trial for CRS prevention in blood cancer patients. While some see …
‘It’s going to be extremely hot’: workers imperiled as sweltering World Cup temperatures are forecast
The panel agrees that heat risks pose operational challenges and potential costs for the 2026 World Cup, but there's no …